Management of shunt related infections

Advances in Experimental Medicine and Biology

Volumn 719, Issue , 2011, Pages 105-115

  Al Dabbagh, Mona ^a   Dobson, Simon ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; FLUCONAZOLE; GENTAMICIN; LINEZOLID; MEROPENEM; MINOCYCLINE; NAFCILLIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULBACTAM; SULTAMICILLIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC IMPREGNATED EXTERNAL VENTRICULAR DRAIN; ANTIBIOTIC IMPREGNATED SHUNT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL SUTURE WOUND CLOSURE; ARTICLE; BACTERIAL COLONIZATION; CATHETER; DEVICE REMOVAL; DOUBLE GLOVING; DRUG EFFICACY; DRUG MONITORING; ENTEROCOCCUS; ESCHERICHIA COLI; HUMAN; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROPIONIBACTERIUM; PSEUDOMONAS AERUGINOSA; SHUNT INFECTION; TREATMENT DURATION; WOUND CLOSURE;

CEREBROSPINAL FLUID SHUNTS; HUMANS; SURGICAL WOUND INFECTION; VENTRICULOPERITONEAL SHUNT;

EID: 83455244392     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0204-6_9     Document Type: Article

References (60)

1. Borgbjerg BM , Gjerris F, Albeck MJ, Borgesen SE. Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995;36(1-2):1-7.
2. Caldarelli M, Rocco C, Marca FL. Shunt complications in the first postoperative year in children with myelomeningocele. Childs Nerv Syst 1996;12(12):748-54. (Pubitemid 27008359)
3. George R, Leibrock L, Epstein M Long-term analysis of cerebrospinal fluid shunt infections. A 25 year experience. J Neurosurg. 1979;51(6):804-11. (Pubitemid 10157871)
4. McGirt MJ, Leveque J-C, Wellons III JC, Villavicencio AT, Hopkins JS, Fuchs HE, et al. Cerebrospinal Fluid Shunt Survival and Etiology of Failures: A Seven-Year Institutional Experience. Pediatric Neurosurgery 2002;36(5):248-55. (Pubitemid 34621738)
5. Cochrane DD, Kestle J. Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001. Eur J Pediatr Surg 2002;12(S11):S6-11. (Pubitemid 36125456)
6. Simon TD, Hall M, Riva-Cambrin J, Albert JE, Jeffries HE, Lafleur B, Dean JM, Kestle JR ; Hydrocephalus Clinical Research Network. Infection rates following initial cerebrospinal fluid shunt placement across pediatric hospitals in the United States. Neurosurg Pediatr 2009;4(2):156-65.
7. Kulkarni AV, Drake JM, Lamberti-Pasculli M. Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg. 2001;94(2):195-201. (Pubitemid 32799678)
8. Langley JM, Gravel D, Moore D, Matlow A, Embree J, MacKinnon-Cameron D, Conly D. Study of Cerebrospinal Fluid Shunt-Associated Infections in the First Year Following Placement, by the Canadian Nosocomial Infection Surveillance Program. infection control and hospital epidemiology 2009;30(3):285-88.
9. Clemmensen D, Rasmussen MM, Mosdal C. A retrospective study of infections after primary VP shunt placement in the newborn with myelomeningocele without prophylactic antibiotics. Childs Nerv Syst. 2010;26(11): 1517-21.
10. Sarguna P, Lakshmi V. Ventriculoperitoneal shunt infections. Indian Journal of Medical Microbiology 2006;24(1):52-4.
11. Brook I. Meningitis and shunt infection caused by anaerobic bacteria in children. Pediatr Neurol. 2002;26(2): 99-105. (Pubitemid 34207807)
12. Montero A, Romero J, Vargas JA, Regueiro CA, Sánchez-Aloz G, De Prados F, De la Torre A, and Aragon G. Candida Infection of Cerebrospinal Fluid Shunt Devices: Report of Two Cases and Review of the Literature. Acta Neurochir (Wien) 2000;142(1):67-74. (Pubitemid 30068277)
13. Benca J, Ondrusova A, Huttova M̊, Rudinsky B, Kisac P, Bauer F. Neuroinfections due to Enterococcus faecalis in children. Neuro Endocrinol Lett. 2007;28(S2):S32-3.
14. Sanchez-Portocarrero J, Martin-Rabadan P, Saldana CJ, Perez-Cecilia E. Candida cerebrospinal Fluid shunt infections. Report of two new cases and review of the literature. Diagn Microbiol Infect Dis 1994;20(1): 33-40. (Pubitemid 124010800)
15. Turgut M, Alabaz D, Erbey F, Kocabas E, Erman T, Alhan E, Aksaray N. Cerebrospinal fluid shunt infections in children. Pediatr Neurosurg. 2005; 41(3):131-6. (Pubitemid 40911587)
16. Montano N, Sturiale C, Paternoster G, Lauretti L, Fernandez E, Pallini R. Massive ascites as unique sign of shunt infection by Propionibacterium acnes. Br J Neurosurg. 2010;24(2):221-3.
17. Fux CA, Quigley M, Worel AM , Post C , Zimmerli S , Ehrlich G , Veeh RH. Biofilm-related infections of cerebrospinal fluid shunts. Clin Microbiol Infect. 2006;12(4):331-7. (Pubitemid 43337522)
18. Braxton EE Jr, Ehrlich GD, Hall-Stoodley L, Stoodley P, Veeh R, Fux C, Hu FZ, Quigley M, Post JC. Role of biofilms in neurosurgical device-related infections. Neurosurg Rev. 2005;28(4):249-55. (Pubitemid 41317895)
19. Kestle JRW, Garton HJL, Whitehead WE, Drake JM, Kulkarni AV, Cochrane DD, Muszynski C, and Walker ML. Management of shunt infections: a multicenter pilot study. J Neurosurgery 2006;105(S3):S177-81.
20. Schreffler RT, Schreffler A, Wittler RR. Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002;21(7):632-6. (Pubitemid 34761443)
21. James HE, Walsh JW, Wilson HD, Connor JD, Bean JR, Tibbs PA. The management of cerebrospinal fluid shunt infections: a clinical experience. Acta Neurochir (Wien) 1981;59(3-4):157-66. (Pubitemid 12143309)
22. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39(9):1267-84. (Pubitemid 39458512)
23. Gombert ME, Landesman SH, Corrado ML, Stein SC, Melvin ET, Cummings M. Vancomycin and rifampin therapy for Staphylococcus epidermidis meningitis associated with CSF shunts: report of three cases. J Neurosurg. 1981;55(4):633-6. (Pubitemid 12227599)
24. Maranich AM, Rajnik M. Successful treatment of vancomycin-resistant enterococcal ventriculitis in a pediatric patient with linezolid. Mil Med. 2008;173(9):927-9.
25. Castro P, Soriano A, Escrich C , Villalba G , Sarasa M , Mensa J. Linezolid treatment of ventriculoperitoneal shunt infection without implant removal. Eur J Clin Microbiol Infect Dis. 2005;24(9):603-6. (Pubitemid 41456140)
26. Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother. 2007;41(2):296-308. (Pubitemid 46340060)
27. Yilmaz A, Dalgic N, Müslüman M , Sancar M , Colak I , Aydin Y. Linezolid treatment of shunt-related cerebrospinal fluid infections in children. J Neurosurg Pediatr. 2010;5(5):443-8.
28. Wen DY, Bottini AJ, Hall WA, Haines SJ. The intraventricular use of antibiotics. Neurosurg Clin North Am 1992;3(2):343-54.
29. Arnell K, Enblad P, Wester T, Sjölin J. Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections. J Neurosurg. 2007;107(S 3): S 213-9.
30. Chiou CC, Wong TT, Lin HH, Hwang B, Tang RB, Wu KG , Lee BH. Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 1994;19(6):1049-53. (Pubitemid 24380017)
31. Shapiro S, Javed T, Mealey J,. Candida albicans shunt infection. Pediatr Neurosci 1989; 15:125-30. (Pubitemid 20309530)
32. Pappas PG, Kauffman C, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503-35.
33. James HE, Bradley JS. Management of complicated shunt infections: a clinical report. J Neurosurg Pediatr. 2008;1(3):223-8. (Pubitemid 351350575)
34. Choksey MS, Malik IA. Zero tolerance to shunt infections: can it be achieved? J Neurol Neurosurg Psychiatry 2004;75(1):87-91. (Pubitemid 38091274)
35. Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatr. 2008;1(1):48-56. (Pubitemid 351396993)
36. Nejat F, Tajik P, El Khashab M, Kazmi SS, Khotaei GT, Salahesh S. A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection. J Microbiol Immunol Infect. 2008;41(2):112-7.
37. Tacconelli E, Cataldo MA, Albanese A, Tumbarello M, Arduini E, Spanu T, et al. Vancomycin versus cefazolin prophylaxis for cerebrospinal shunt placement in a hospital with a high prevalence of meticillin-resistant Staphylococcus aureus. J. Hosp Infect 2008;69(4):337-44.
38. Wong GK, Poon WS, Lyon D, Wai S. Cefepime vs. Ampicillin/Sulbactam and Aztreonam as antibiotic prophylaxis in neurosurgical patients with external ventricular drain: result of a prospective randomized controlled clinical trial. J Clin Pharm Ther. 2006;31(3):231-5. (Pubitemid 43873545)
39. Pattavilakom A, Xenos C, Bradfield O, Danks RA. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci. 2007;14(6):526-31. (Pubitemid 46550900)
40. Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, et al. Efficacy of antimicrobialimpregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725-30. (Pubitemid 36396773)
41. Muttaiyah S, Ritchie S, John S, Mee E, Roberts S. Efficacy of antibiotic-impregnated external ventricular drain catheters. J Clin Neurosci. 2010;17(3):296-8.
42. Richards HK, Seeley HM, Pickard JD. Efficacy of antibiotic-impregnated shunt catheters in reducing shunt infection: data from the United Kingdom Shunt Registry. J Neurosurg Pediatr. 2009;4(4):389-93.
43. Gutiérrez-González R, Boto GR, Fernández- Pérez C, Del Prado N. Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures. BMC Neurol. 2010;10:93.
44. Sciubba DM, Lin LM, Woodworth GF, McGirt MJ, Carson B, Jallo GI. Factors contributing to the medical costs of cerebrospinal fluid shunt infection treatment in pediatric patients with standard shunt components compared with those in patients with antibiotic impregnated components. Neurosurg Focus. 2007;22(4):E9.
45. Parker SL, Attenello FJ, Sciubba DM, Garces-Ambrossi GL, Ahn E, Weingart J, et al. Comparison of shunt infection incidence in high-risk subgroups receiving antibiotic-impregnated versus standard shunts. Childs Nerv Syst. 2009;25(1):77-83.
46. Govender ST, Nathoo N, Van Dellen JR. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg Pediatr. 2003;99(5):831-9. (Pubitemid 37314917)
47. Albanese A, De Bonis P, Sabatino G, Capone G, Marchese E, Vignati A, et al. Antibiotic-impregnated ventriculo-peritoneal shunts in patients at high risk of infection. Acta Neurochir (Wien) 2009;151(10):1259-63.
48. Wong GK, Poon WS, Ng SC, Ip M. The impact of ventricular catheter impregnated with antimicrobial agents on infections in patients with ventricular catheter: interim report. Acta Neurochir Suppl. 2008;102: 53-5.
49. Hayhurst C, Williams D, Kandasamy J, O'Brien DF, Mallucci CL. The impact of antibiotic-impregnated catheters on shunt infection in children and neonates. Childs Nerv Syst. 2008;24(5):557-62. (Pubitemid 351566604)
50. Stevens EA, Palavecino E, Sherertz RJ, Shihabi Z, Couture DE. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis. J. Neurosurg. 2010;113(1):86-92.
51. Gruber TJ, Reimer S, Rozelle C. Pediatric Neurosurgical Practice Patterns Designated to prevent Cerebrospinal Fluid shunt infection. Pediatric Neurosurgery 2009;45(6):456-60.
52. Rehman AU, Rehman TU, Bashir HH, Gupta V. A simple method to reduce infection of ventriculoperitoneal shunts. J Neurosurg Pediatr. 2010;5(6):569-72.
53. Dasic D, Hanna SJ, Bojanic S, Kerr RS. External ventricular drain infection: the effect of a strict protocol on infection rates and a review of the literature. Br J Neurosurg. 2006;20(5):296-300. (Pubitemid 44863789)
54. Rozzelle CJ, Leonardo J, Li V. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: a prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr. 2008;2(2):111-7.
55. Stone J, Gruber TJ, Rozzelle CJ. Healthcare savings associated with reduced infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures. Pediatr Neurosurg. 2010;46(1):19-24.
56. Shaikh ZH, Peloquin CA, Ericsson CD Successful treatment of vancomycin-resistant Enterococcus faecium meningitis with linezolid: case report and literature review. Scand J Infect Dis. 2001;33(5):375-9. (Pubitemid 32573988)
57. Williamson JC, Glazier SS, Peacock JEJ. Successful treatment of ventriculostomy-related meningitis caused by vancomycin-resistant Enterococcus with intravenous and intraventricular quinupristin/dalfopristin Clin Neurol Neurosurg 2002;104(1):54-6. (Pubitemid 34048329)
58. Arnell K, Cesarini K, Lagerqvist-Widh A, Wester T, Sjölin J. Cerebrospinal fluid shunt infections in children over a 13-year period: anaerobic cultures and comparison of clinical signs of infection with Propionibacterium acnes and with other bacteria. J Neurosurg Pediatr. 2008;1(5):366-72. (Pubitemid 351670702)
59. Bayston R, Nuradeen B, Ashraf W, Freeman BJ. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother. 2007;60(6):1298-301. (Pubitemid 350168326)
60. Murphy K, Bradley J, James HE. The treatment of Candida albicans shunt infections. Childs Nerv Syst. 2000;16(1):4-7. (Pubitemid 30139608)